Clinical Study to Evaluate XS411 in Treatment of Early-onset Parkinson's Disease

Clinical trial NCT07166757 · RECRUITING

Trial details

NCT number: NCT07166757
Sponsor: XellSmart Bio-Pharmaceutical (Suzhou) Co., Ltd.
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Parkinson Disease (PD)

Start date: 2025-09-22
Primary completion: 2028-03-30
Enrollment: 90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.